IMAGE-HF: Project IIa Canadian CArdiomyopathy Registry for Device Therapy
CanCARD-MR
IMAGE-HF: Project IIa - Canadian CArdiomyopathy Registry for Device Therapy (CanCARD-MR)
1 other identifier
observational
502
0 countries
N/A
Brief Summary
Delayed enhanced MRI in patients (of either ischemic or non-ischemic cause) being referred for primary prevention ICD
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2011
CompletedFirst Submitted
Initial submission to the registry
May 26, 2021
CompletedFirst Posted
Study publicly available on registry
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedFebruary 28, 2023
February 1, 2023
11.8 years
May 26, 2021
February 27, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Occurrence of a)appropriate ICD therapy (shock or anti-tachycardia pacing (ATP)) or sudden cardiac death
Occurrence of a)appropriate ICD therapy (shock or anti-tachycardia pacing (ATP)) or sudden cardiac death
1 year
Eligibility Criteria
Patients referred for or being considered for primary prevention ICD, with or without CRT, will be recruited from the Electrophysiology services at each enrolling site
You may qualify if:
- Any patient accepted for primary prevention ICD (+/-) CRT)
You may not qualify if:
- Known contra-indications to MRI.
- Recent myocardial infarction or revascularization procedure within the past 3 months.
- GFR (glomerular filtration rate) ≤ 30 ml. / min/ m2.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Birnie
Ottawa Heart Institute Research Corporation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2021
First Posted
June 1, 2021
Study Start
October 11, 2011
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
February 28, 2023
Record last verified: 2023-02